Xiaobin Wu - BeiGene COO Pres

B1GN34 Stock  BRL 42.30  1.46  3.34%   

Insider

Xiaobin Wu is COO Pres of BeiGene
Age 61
Phone781-801-1800
Webhttps://www.beigene.com

Xiaobin Wu Latest Insider Activity

Tracking and analyzing the buying and selling activities of Xiaobin Wu against BeiGene stock is an integral part of due diligence when investing in BeiGene. Xiaobin Wu insider activity provides valuable insight into whether BeiGene is net buyers or sellers over its current business cycle. Note, BeiGene insiders must abide by specific rules, including filing SEC forms every time they buy or sell BeiGene'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

BeiGene Management Efficiency

The company has return on total asset (ROA) of (0.1971) % which means that it has lost $0.1971 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5254) %, meaning that it generated substantial loss on money invested by shareholders. BeiGene's management efficiency ratios could be used to measure how well BeiGene manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Amit SachdevVertex Pharmaceuticals Incorpor
50
Lotte SonderbjergAscendis Pharma AS
62
Stephane BancelModerna
50
Jeffrey MDVertex Pharmaceuticals Incorpor
67
Sylke MaasBIONTECH SE DRN
N/A
John ReyndersModerna
N/A
Kennett SprogoeAscendis Pharma AS
44
Michael BoehlerBIONTECH SE DRN
N/A
James MockModerna
46
Michael LLMAscendis Pharma AS
52
Paul SilvaVertex Pharmaceuticals Incorpor
51
Susie LisaVertex Pharmaceuticals Incorpor
N/A
Stephen MDModerna
47
Francisco CostaBiomm SA
N/A
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
50
David AltshulerVertex Pharmaceuticals Incorpor
53
Jan MikkelsenAscendis Pharma AS
63
Peter RasmussenAscendis Pharma AS
54
Jens OkkelsAscendis Pharma AS
62
Lloyd CarneyVertex Pharmaceuticals Incorpor
57
Ozlem MDBIONTECH SE DRN
56
BeiGene (B1GN34) is traded on Sao Paulo Exchange in Brazil and employs 9,000 people.

Management Performance

BeiGene Leadership Team

Elected by the shareholders, the BeiGene's board of directors comprises two types of representatives: BeiGene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BeiGene. The board's role is to monitor BeiGene's management team and ensure that shareholders' interests are well served. BeiGene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BeiGene's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Oyler, Ex CoFounder
Xiaodong Wang, Chairman CoFounder
Mi Zhou, Director Relations
Daniel Maller, VP Accounting
Chan Lee, G Counsel
Wang Lai, Global RD
Kevin Mannix, VP Relations
Diana Francis, VP Compliance
Julia Wang, CFO Officer
Xiaobin Wu, COO Pres

BeiGene Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BeiGene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in BeiGene Stock

When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.